Since both IFN-β and AhR signaling in astrocytes have previously been linked to an anti-inflammatory and tissue-protective phenotype in the context of MS and EAE11,12, this may indicate that PD-L1 signaling might contribute to these regulatory functions. Here, AHR is linked to myeloid sarcoma.